Making antimalarial agents available in Africa

Article Abstract:

The Chinese government scientists confirmed the antimalarial properties of compounds extracted from Artemisia annua, and many artemisinin-based drugs are produced to prevent malaria that has spread widely in rural Africa. Artemisinins cost 10 times more than chloroquine, an inexpensive, safe and effective drug and the malaria-control communities, and other leading authorities have endorsed the concept of combination therapies as the new standard that are also not available at affordable prices.

Government domestic functions, Africa, Health policy

---

Making antimalarial agents available in the United States

Article Abstract:

Plasmodium falciparum is increasingly becoming resistant to agents such as chloroquine and sulfadoxine-pyrimethamine, arteminisinin pills and rectal suppositories, which are the best presumptive treatment in areas in which the organism is highly endemic. Intravenous quinine and oral, rectal, intravenous artemisinins are not approved by the Food and Drug Administration (FDA) and are not available in the United States.

---

Effectiveness of antimalarial drugs

Article Abstract:

The collapse of preventive efforts and the waning efficacy of standard antimalarial drugs account for the global resurgence of malaria. Efforts to use new antimalarial drugs may be hampered by regulatory requirements or economic obstacles as well as by important questions about safety for the large numbers of patients who treat themselves.

Usage, Prevention

Similar abstracts:

• Abstracts: Placenta previa: neonatal death after live births in the United States. The association of parity with mortality outcomes among triplets
• Abstracts: Prevalence of chlamydial and gonococcal infections amog young adults in the United States
• Abstracts: Combating antibiotic resistance. Antibacterial properties of self-etching dental adhesive systems. 'Smart' antimicrobial treatment developed
• Abstracts: Assessing the effectiveness of antiretroviral adherence interventions: Using marginal structural models to replicate the findings of randomized controlled trials
• Abstracts: Protocols are no substitute for instinct. RMNs branded as 'idle' by others. Implementing the essence of care benchmark for pressure ulcers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.